Variant report

Variant	esv275147
Chromosome Location	chr17:16845167-16848750
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTCF	chr17:16848178-16848226	GM19239	blood:	n/a	n/a
2	ELF1	chr17:16847839-16848557	GM12878	blood:	n/a	n/a
3	GATA3	chr17:16845404-16846309	MCF-7	breast:	n/a	n/a
4	MAX	chr17:16845144-16845240	NB4	blood:	n/a	n/a
5	MAX	chr17:16848104-16848413	NB4	blood:	n/a	chr17:16848278-16848288 chr17:16848216-16848226
6	MYC	chr17:16848118-16848404	NB4	blood:	n/a	chr17:16848278-16848288 chr17:16848216-16848226
7	NFATC1	chr17:16848303-16848733	GM12878	blood:	n/a	n/a
8	NFATC1	chr17:16844715-16845420	GM12878	blood:	n/a	n/a
9	NFATC1	chr17:16845899-16847187	GM12878	blood:	n/a	n/a
10	NFATC1	chr17:16847415-16848300	GM12878	blood:	n/a	n/a
11	NFATC1	chr17:16845144-16845436	GM12878	blood:	n/a	n/a
12	NR2F2	chr17:16845392-16846398	MCF-7	breast:	n/a	n/a
13	POLR2A	chr17:16846052-16846793	GM12878	blood:	n/a	n/a
14	POLR2A	chr17:16848320-16848659	GM12891	blood:	n/a	n/a
15	POLR2A	chr17:16846165-16849578	GM19193	blood:	n/a	n/a
16	POLR2A	chr17:16846807-16847655	GM12878	blood:	n/a	n/a
17	POLR2A	chr17:16847656-16849067	GM12878	blood:	n/a	n/a
18	POLR2A	chr17:16845599-16849822	GM12878	blood:	n/a	n/a
19	POLR2A	chr17:16845851-16846027	GM12878	blood:	n/a	n/a
20	POLR2A	chr17:16847431-16848363	GM12892	blood:	n/a	n/a
21	POLR2A	chr17:16846057-16849577	GM12878	blood:	n/a	n/a
22	POLR2A	chr17:16845628-16849512	GM12892	blood:	n/a	n/a
23	POLR2A	chr17:16847656-16848455	GM12891	blood:	n/a	n/a
24	POLR2A	chr17:16846219-16849536	GM12892	blood:	n/a	n/a
25	POLR2A	chr17:16846099-16848820	GM12892	blood:	n/a	n/a
26	POLR2A	chr17:16845984-16847242	GM12878	blood:	n/a	n/a
27	POLR2A	chr17:16846119-16846909	GM12878	blood:	n/a	n/a
28	POLR2A	chr17:16845166-16845366	GM12878	blood:	n/a	n/a
29	POLR2A	chr17:16845221-16849358	GM12878	blood:	n/a	n/a
30	POLR2A	chr17:16847064-16848246	GM18951	blood:	n/a	n/a
31	POLR2A	chr17:16846878-16847172	GM12891	blood:	n/a	n/a
32	POLR2A	chr17:16845763-16848912	GM18505	blood:	n/a	n/a
33	POLR2A	chr17:16847497-16848158	GM12891	blood:	n/a	n/a
34	POLR2A	chr17:16848582-16848583	GM12878	blood:	n/a	n/a
35	POLR2A	chr17:16845998-16849832	GM12892	blood:	n/a	n/a
36	POLR2A	chr17:16845603-16845860	GM12878	blood:	n/a	n/a
37	POLR2A	chr17:16846911-16848568	GM12878	blood:	n/a	n/a
38	POLR2A	chr17:16847979-16848291	GM12891	blood:	n/a	n/a
39	POLR2A	chr17:16846485-16846872	GM12891	blood:	n/a	n/a
40	STAT5A	chr17:16846680-16847324	GM12878	blood:	n/a	n/a
41	USF1	chr17:16848110-16848285	HepG2	liver:	n/a	chr17:16848216-16848227
42	USF1	chr17:16848065-16848376	HepG2	liver:	n/a	chr17:16848216-16848227
43	USF2	chr17:16848148-16848268	Hela-S3	cervix:	n/a	chr17:16848216-16848227
44	USF2	chr17:16848114-16848314	HepG2	liver:	n/a	chr17:16848216-16848227

No.	Distal block	Cell Line	Cell type
1	chr17:16826192..16826763-chr17:16845300..16846108,3	MCF-7	breast:
2	chr17:16844634..16847567-chr17:17108440..17110491,2	MCF-7	breast:
3	chr17:16825314..16827941-chr17:16845624..16848889,3	MCF-7	breast:
4	chr17:16844584..16846721-chr17:16858506..16861138,2	MCF-7	breast:

Variant related genes	Relation type
TNFRSF13B	TF binding region
ENSG00000179598	chromatin interactions

Extended variants
information (count: 161 )
Associated
traits (count: 158 )

Variant overlapped rSNPs/rCNVs (count:161 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4792800	chr17:16845167-16845168	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	disease
2	rs567347184	chr17:16845179-16845180	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs8079680	chr17:16845230-16845231	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs144739074	chr17:16845242-16845243	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs570143669	chr17:16845277-16845278	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs34694042	chr17:16845288-16845289	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs538755918	chr17:16845312-16845313	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs558969792	chr17:16845328-16845329	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs566328530	chr17:16845337-16845338	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs535359460	chr17:16845360-16845361	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs8081126	chr17:16845362-16845363	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
12	rs574495397	chr17:16845385-16845386	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs11651187	chr17:16845402-16845403	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
14	rs4791698	chr17:16845458-16845459	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
15	rs4792801	chr17:16845467-16845468	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
16	rs546016156	chr17:16845492-16845493	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs559302789	chr17:16845505-16845506	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs138884331	chr17:16845530-16845531	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs541726551	chr17:16845576-16845577	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs148949270	chr17:16845581-16845582	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs192956198	chr17:16845587-16845588	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs373925117	chr17:16845588-16845589	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs140006798	chr17:16845601-16845602	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs563837328	chr17:16845625-16845626	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs112220128	chr17:16845639-16845640	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs552709894	chr17:16845673-16845674	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs185367821	chr17:16845700-16845701	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs535296782	chr17:16845734-16845735	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs543962573	chr17:16845759-16845760	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs188409695	chr17:16845782-16845783	Weak transcription Enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs560508950	chr17:16845815-16845816	Weak transcription Bivalent Enhancer Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs28599508	chr17:16845830-16845831	Weak transcription Bivalent Enhancer Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs142032470	chr17:16845846-16845847	Weak transcription Bivalent Enhancer Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs544737895	chr17:16845850-16845851	Weak transcription Bivalent Enhancer Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs556767661	chr17:16845869-16845870	Weak transcription Bivalent Enhancer Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs546968054	chr17:16845880-16845881	Weak transcription Bivalent Enhancer Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs147326188	chr17:16845902-16845903	Weak transcription Bivalent Enhancer Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs539182971	chr17:16845924-16845925	Weak transcription Bivalent Enhancer Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs553087861	chr17:16845929-16845930	Weak transcription Bivalent Enhancer Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs572739888	chr17:16845941-16845942	Weak transcription Bivalent Enhancer Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs181231879	chr17:16845943-16845944	Weak transcription Bivalent Enhancer Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs11656868	chr17:16845995-16845996	Weak transcription Bivalent Enhancer Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs139314675	chr17:16846013-16846014	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs543764304	chr17:16846019-16846020	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs78790736	chr17:16846030-16846031	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs532592046	chr17:16846068-16846069	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs143237103	chr17:16846119-16846120	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs59401088	chr17:16846152-16846153	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs12938061	chr17:16846155-16846156	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
50	rs12938073	chr17:16846176-16846177	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance

Variant related diseases (count:158)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Colorectal cancer	16774939	CNVD
Pancreatic cancer	21811587	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Gastric cancer	18160780	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Breast cancer	21509527	CNVD
Ductal carcinoma	22052326	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Multiple myeloma	17550852	CNVD

Chromatin state (count:75 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:16840800-16847400	Strong transcription	GM12878-XiMat	blood
2	chr17:16841000-16846600	Strong transcription	Primary B cells from peripheral blood	blood
3	chr17:16842400-16846400	Weak transcription	Brain Anterior Caudate	brain
4	chr17:16842600-16849200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
5	chr17:16843800-16848000	Enhancers	Fetal Muscle Leg	muscle
6	chr17:16844200-16846400	Weak transcription	Brain Substantia Nigra	brain
7	chr17:16844200-16847000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr17:16844200-16848000	Weak transcription	Spleen	Spleen
9	chr17:16844200-16848600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
10	chr17:16844200-16848800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
11	chr17:16844200-16849000	Weak transcription	H1 Cell Line	embryonic stem cell
12	chr17:16844200-16849200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
13	chr17:16844200-16852000	Weak transcription	H9 Cell Line	embryonic stem cell
14	chr17:16844400-16848800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
15	chr17:16844400-16848800	Weak transcription	HUES48 Cell Line	embryonic stem cell
16	chr17:16844400-16848800	Weak transcription	HUES64 Cell Line	embryonic stem cell
17	chr17:16844600-16845800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
18	chr17:16844600-16847000	Weak transcription	Primary B cells from cord blood	blood
19	chr17:16844800-16845200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
20	chr17:16844800-16845400	Enhancers	Adipose Nuclei	Adipose
21	chr17:16844800-16846600	Enhancers	Fetal Muscle Trunk	muscle
22	chr17:16844800-16848600	Weak transcription	HUES6 Cell Line	embryonic stem cell
23	chr17:16844800-16848600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
24	chr17:16845000-16845200	Enhancers	Brain Angular Gyrus	brain
25	chr17:16845000-16845200	Enhancers	Brain Cingulate Gyrus	brain
26	chr17:16845000-16845400	Enhancers	Brain Hippocampus Middle	brain
27	chr17:16845200-16845400	Enhancers	Brain Inferior Temporal Lobe	brain
28	chr17:16845200-16846400	Weak transcription	Brain Cingulate Gyrus	brain
29	chr17:16845400-16846200	Weak transcription	Brain Inferior Temporal Lobe	brain
30	chr17:16845400-16846400	Weak transcription	Brain Hippocampus Middle	brain
31	chr17:16845400-16846800	Weak transcription	Brain Angular Gyrus	brain
32	chr17:16845800-16846000	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
33	chr17:16845800-16846200	Enhancers	Fetal Intestine Small	intestine
34	chr17:16845800-16846600	Enhancers	Fetal Intestine Large	intestine
35	chr17:16845800-16846600	Enhancers	A549	lung
36	chr17:16846000-16846600	Bivalent Enhancer	HepG2	liver
37	chr17:16846200-16846400	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
38	chr17:16846200-16846400	Enhancers	Pancreas	Pancrea
39	chr17:16846200-16847800	Enhancers	Brain Inferior Temporal Lobe	brain
40	chr17:16846400-16847600	Enhancers	Brain Substantia Nigra	brain
41	chr17:16846400-16848200	Enhancers	Brain Anterior Caudate	brain
42	chr17:16846400-16850400	Enhancers	Brain Hippocampus Middle	brain
43	chr17:16846400-16851600	Enhancers	Brain Cingulate Gyrus	brain
44	chr17:16846600-16847800	Weak transcription	Fetal Intestine Large	intestine
45	chr17:16846600-16848200	Weak transcription	Pancreas	Pancrea
46	chr17:16846600-16848800	Weak transcription	A549	lung
47	chr17:16846600-16849400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
48	chr17:16846600-16852000	Genic enhancers	Primary B cells from peripheral blood	blood
49	chr17:16846800-16847400	Enhancers	Brain Angular Gyrus	brain
50	chr17:16847000-16847200	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links